IP Verse

Ophthalmological Composition - EP3426226B1

PatentPatent Analysis

EP3426226

URSAPHARM ARZNEIMITTEL
Application Number
EP17709641A
Filing Date
Mar 7, 2017
Status
Revoked
Aug 30, 2024
Grant Date
May 4, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2429507B1

Bibliography

The patent EP3426226B1 was granted to Ursapharm Arzneimittel on May 4, 2022 following the initial filing on Mar 7, 2017 under the application number EP17709641A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BITOPFeb 3, 2023ADMISSIBLE
BAUSCH LOMB IRELANDFeb 2, 2023ADMISSIBLE
PHARMA STULLNJun 9, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents